Centre de documentació: resultats de cerca | Siidon | Guttmann

Cercador

Medical Big Data for Studying Cerebral Amyloid Angiopathy: New Opportunities, Familiar Challenges.
Autor/s:
Anderson CS.
Editorial
Any publicació:
2025
Número de revista:
Neurology vol. 104 n. 10
https://www.neurology.org/doi/full/10.1212/WNL.0000000000213741
Correction
Increased Risk of Misdiagnosis and Treatment Complication in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Autor/s:
Marignier R, Hacohen Y.
Editorial
Any publicació:
2025
Número de revista:
Neurology vol. 104 n. 10
https://www.neurology.org/doi/full/10.1212/WNL.0000000000213681
A Newly Validated Gold Standard for Measuring Multiple Sclerosis Disability Worsening.
Autor/s:
Fox RJ, Rudick RA.
Editorial
Any publicació:
2025
Número de revista:
Neurology vol. 104 n. 10
https://www.neurology.org/doi/full/10.1212/WNL.0000000000213672
Juvenile Huntington Disease: Timing Is Everything.
Autor/s:
Schultz JL, Nopoulos P.
Editorial
Any publicació:
2025
Número de revista:
Neurology vol. 104 n. 10
https://www.neurology.org/doi/full/10.1212/WNL.0000000000213631
Article
Comparison of the Clinical Spectrum of Juvenile- and Adult-Onset Huntington Disease: A National Cohort and Enroll-HD Observational Study.
Autor/s:
Bakels HS, van der Zwaan KF, Van Zwet E, Reijntjes R, Sprenger GP, Knecht TA, Roos RAC, de Bot ST.
Any publicació:
2025
Número de revista:
Neurology vol. 104 n. 10
https://www.neurology.org/doi/full/10.1212/WNL.0000000000213525
Article
Prevalence and 10-Year Risk of Intracerebral Hemorrhage in Central China Using Estimates From the 1 Million Cross-Sectional Study.
Autor/s:
Zhang Y, Yang S, Wang S, Zou X, Tang L, Chen L, Ma J, Li Y, Yao T, Zhang X, Tang R, Tang L, Zhang F, Zhou H, Xu L, Tang Q, Ma S, Yi Y, Liu R, Bai G, Zeng Y, Zhou Y, Zhao Y, Wang Y, Yang Q, Wang D, Shen M, Zhang L.
Any publicació:
2025
Número de revista:
Neurology vol. 104 n. 10
https://www.neurology.org/doi/full/10.1212/WNL.0000000000213545
Article
Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Autor/s:
Dinoto A, Cacciaguerra L, Vorasoot N, Redenbaugh V, Lopez-Chiriboga SA, Valencia-Sanchez C, Guo K, Thakolwiboon S, Horsman SE, Syc-Mazurek SB, Tisavipat N, Mandrekar J, Tajfirouz D, Eggenberger ER, Pless ML, Chodnicki K, Tillema JM, Pittock SJ, Chen JJ, Flanagan EP.
Any publicació:
2025
Número de revista:
Neurology vol. 104 n. 10
https://www.neurology.org/doi/full/10.1212/WNL.0000000000213557
Article
Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical Trials.
Autor/s:
Kappos L, Yiu S, Dahlke F, Coetzee T, Cutter GR, Yuen S, Bonati U, Lublin FD.
Any publicació:
2025
Número de revista:
Neurology vol. 104 n. 10
https://www.neurology.org/doi/full/10.1212/WNL.0000000000213558
Article
Association Between Metabolic Syndrome and Young-Onset Dementia: A Nationwide Population-Based Study.
Autor/s:
Lee JY, Han K, Kim J, Lim JS, Cheon DY, Lee M.
Any publicació:
2025
Número de revista:
Neurology vol. 104 n. 10
https://www.neurology.org/doi/full/10.1212/WNL.0000000000213599
Article
Investigating Plasma Metabolomics and Gut Microbiota Changes Associated With Parkinson Disease: A Focus on Caffeine Metabolism.
Autor/s:
Chen CC, Chiu JY, Tan AH, Toh TS, Lim SY, Tan EK, Pettersson S, Hsu CC, Liou JM, Wu MS, Hsu CL, Lin CH.
Any publicació:
2025
Número de revista:
Neurology vol. 104 n. 10
https://www.neurology.org/doi/full/10.1212/WNL.0000000000213592